Postantibiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 414-418

  Fuentes, F ^a   Izquierdo, J ^a   Martin M M ^a   Gomez Lus, M L ^a   Prieto, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ISEPAMICIN; ANTIINFECTIVE AGENT; GENTAMICIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ESCHERICHIA COLI; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; ESCHERICHIA COLI; FEMALE; GENTAMICINS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 0031594748     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bigger, J. W. 1944. The bactericidal action of penicillin on Staphylococcus pyogenes. Ir. J. Med. Sci. 227:533-568.
2. Cars, O., and I. Odenholt-Tornqvist. 1993. The post-antibiotic sub-MIC effect in vitro and in vivo. J. Antimicrob. Chemother. 31(Suppl. D):159-166.
3. Craig, W. A. 1993. Post-antibiotic effects in experimental infection models: relationship to in vitro phenomena and to treatment of infection in man. J. Antimicrob. Chemother. 31(Suppl. D):149-158.
4. Craig, W. A., and S. Gudmundsson. 1991. The postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins Co., Baltimore, Md.
5. Debbia, E. A., G. Molinari, P. Paglai, and G. C. Schito. 1990. Postantibiotic effect of azithromycin on respiratory tract pathogens. Drugs Exp. Clin. Res. 16:615-619.
6. Eagle, H., R. Fleischman, and A. D. Musselman. 1950. The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms. Ann. Intern. Med. 33:544-571.
7. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
8. Fuentes, F., M. M. Martin, J. Izquierdo, M. L. Gomez-Lus, and J. Prieto. 1995. In vivo and in vitro pharmacodynamic effects of meropenem. Scand. J. Infect. Dis. 27:469-474.
9. Fuentes, F., M. M. Martin, J. Izquierdo, M. L. Gomez-Lus, and J. Prieto. 1996. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro. Chemotherapy 42:354-362.
10. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
11. Gudmundsson, S., S. Einarsson, H. Erlendsdottir, J. Moffat, W. Bayer, and W. A. Craig. 1993. The postantibiotic effect of antimicrobial combinations in neutropenic murine thigh infection model. J. Antimicrob. Chemother. 31 (Suppl. D):177-191.
12. Gudmundsson, S., B. Vogelman, and W. A. Craig. 1986. The in vivo postantibiotic effect of imipenem and other new antimicrobials. J. Antimicrob. Chemother. 18(Suppl. E):67-73.
13. Hesen, M. T., P. G. Pitsakis, and M. E. Levison. 1988. Absence of postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. J. Infect. Dis. 158:542-548.
14. Jones, R. N., A. L. Barry, T. L. Gavan, and J. A. Washington II. 1985. Susceptibility tests: microdilution and macrodilution broth procedures, p. 972-977. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
15. Martín, M. M., F. Fuentes, J. Izquierdo, M. L. Gómez-Lus, and J. Prieto. 1993. In-vivo and in-vitro study of the postantibiotic effect of meropenem. J. Antimicrob. Chemother. 32:917-918. (Letter.)
16. McDonald, P. J., W. A. Craig, and C. M. Kunin. 1977. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135:217-223.
17. McDonald, P. J., and H. Pruul. 1991. Phagocyte uptake and transport of azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 10:828-833.
18. Minguez, F., J. Izquierdo, M. M. Martin, F. Fuentes, and J. Prieto. 1992. In vivo postantibiotic effect of isepamicin and other aminoglycosides in a thigh infection model in neutropenic mice. Chemotherapy 38:179-184.
19. Odenholt, I., S. E. Holm, and O. Cars. 1989. Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J. Antimicrob. Chemother. 24:147-156.
20. Odenholt, I., S. E. Holm, and O. Cars. 1990. Effects of supra and sub-MIC benzylpenicillin concentrations on group A β-haemolytic streptococci during the postantibiotic phase in vivo. J. Antimicrob. Chemother. 26:193-201.
21. Odenholt-Tornqvist, I. 1993. Studies on the postantibiotic sub-MIC effect of meropenem. J. Antimicrob. Chemother. 31:881-892.
22. Odenholt-Tornqvist, I., and S. Bengtsson. 1994. Postantibiotic effect and postantibiotic effect of subinhibitory concentrations of sparfloxacin on Gram-negative bacteria. Chemotherapy 40:30-36.
23. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1991. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
24. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1992. Postantibiotic sub-MIC effects for vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
25. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1995. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrob. Agents Chemother. 39:221-226.
26. Oshida, T., T. Onta, N. Nakanishi, T. Matsushita, and T. Yamaguchi. 1990. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus. J. Antimicrob. Chemother. 26:29-38.
27. Renneberg, J., and M. Walder. 1989. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo. Antimicrob. Agents Chemother. 33:1714-1720.
28. Roosendaal, R., I. A. J. M. Bakker-Woudenberg, J. C. Van den Berg, and M. F. Michel. 1985. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J. Infect. Dis. 152:373-378.
29. Sande, M. A., O. M. Korzeniowski, G. M. Allegro, R. O. Brennan, O. Zak, and W. M. Scheld. 1981. Intermittent or continuous therapy of experimental meningitis due to S. pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev. Infect. Dis. 3:98-109.
30. Vogelman, B., S. Gudmundsson, J. Turnidge, J. Leggett, and W. A. Craig. 1988. In vivo postantibiotic effect in a thigh infection model in neutropenic mice. J. Infect. Dis. 157:287-298.